Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Medical ImagingEndoscopy Equipment

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1861054

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1861054

Rigid Endoscopes Market by Type (Laparoscopes, Arthroscopes, Cystoscopes), Clinical Usage (Diagnostic, Surgical), Application (Laparoscopy, Cystoscopy, Arthroscopy, Other), End User (Hospitals, ASCs, Clinics), Region - Global Forecast to 2030

PUBLISHED:
PAGES: 241 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The global rigid endoscopes market is projected to reach USD 2.32 billion by 2030, growing from USD 1.83 billion in 2025, at a CAGR of 4.9% during the forecast period. The growth of the rigid endoscopes market is driven by the rising prevalence of chronic diseases, increasing demand for minimally invasive surgeries, and advancements in imaging and optics technology.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsType, Clinical Usage, Application, End User, and Region
Regions coveredNorth America, Europe, APAC, RoW

Opportunities exist in emerging markets due to the expansion of healthcare infrastructure, increasing procedural volumes, and rising medical tourism, which enable the adoption of advanced endoscopic solutions. However, market growth faces challenges from risks of viral infections, lack of proper sterilization and reprocessing, and high procedural costs, which may limit widespread adoption, particularly in resource-constrained regions.

Rigid Endoscopes Market - IMG1

The arthroscopes segment is expected to grow at the fastest rate in the rigid endoscopes market during the forecast period.

By type, the rigid endoscopes market is segmented into laparoscopes, urology endoscopes, gynecology endoscopes, arthroscopes, cytoscopes, neuroendoscopes, and other rigid endoscopes. Among these, the urology endoscopes segment accounted for the second-largest market share in 2024, owing to the increasing prevalence of musculoskeletal disorders, particularly among the aging global population. According to the WHO, the number of people aged 60 and above is projected to rise from 1.1 billion in 2023 to 1.4 billion by 2030, creating a substantial patient pool at higher risk for joint-related conditions. Age-related degenerative diseases such as osteoarthritis are becoming more common, with the CDC reporting that arthritis prevalence increases sharply with age-from 3.6% in adults aged 18-34 to 53.9% in individuals 75 and older-driving demand for minimally invasive orthopedic interventions. Arthroscopy offers a precise, less invasive solution for diagnosing and treating joint injuries, reducing recovery time, and improving surgical outcomes, which enhances patient preference and procedural adoption. Additionally, advancements in high-definition imaging, improved surgical instruments, and growing awareness among orthopedic specialists are further accelerating the adoption of arthroscopes, positioning this segment for the fastest growth within the rigid endoscopes market.

The surgical usage segment accounted for the largest share of the rigid endoscopes market in 2024.

By clinical usage, the rigid endoscopes market has been divided into diagnostic & surgical usage. Among these, the surgical usage segment accounted for the largest share of the market in 2024. This is due to the increasing adoption of minimally invasive procedures across multiple specialties, including laparoscopy, arthroscopy, urology, gynecology, and ENT. Rigid endoscopes serve as the core platform for these interventions, offering superior optical clarity, high-definition and 4K visualization, and robust, autoclavable designs that integrate seamlessly with surgical instruments and operating room workflows. The growing preference for minimally invasive surgeries is driven by benefits such as shorter hospital stays, reduced post-operative complications, faster patient recovery, and enhanced clinical outcomes, which directly influence procedure volumes and market demand for rigid scopes.

Asia Pacific is projected to grow at the highest rate in the rigid endoscopes market during the forecast period.

The global rigid endoscopes market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these, the Asia Pacific region is projected to grow at the highest rate during the forecast period. This is primarily due to the development of healthcare infrastructure, increasing healthcare expenditure, and rising awareness of early disease detection across populous nations such as China and India. These countries are investing heavily to enhance diagnostic and surgical capabilities, particularly to manage the rising cases of chronic diseases, such as cancer, pulmonary, and urological disorders. Japan's well-established healthcare system with universal insurance coverage ensures wide accessibility to advanced endoscopic procedures. Moreover, increasing medical tourism, favorable government initiatives, and the rising adoption of minimally invasive technologies are accelerating market penetration, making the Asia Pacific a high-growth region in the global rigid endoscopes market.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1 -40%, Tier 2 -30%, and Tier 3 -30%
  • By Designation: C-level -50%, Director level -30%, and Others -20%
  • By Region: North America -30%, Europe - 25%, Asia Pacific -20%, Latin America -15%, and Middle East & Africa -10%

Notes:

Companies are classified into tiers based on their total revenue. The tiers are as follows: Tier 1 = >USD 10.0 billion, tier 2 = USD 1.0 billion to USD 10.0 billion, and tier 3 = <USD 1.0 billion

C-level primaries include CEOs, CFOs, COOs, and VPs.

Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The players operating in the rigid endoscopes market include Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Stryker (US), Medtronic (Ireland), Smith+Nephew (UK), B Braun SE (Germany), CONMED Corporation (US), Arthrex Inc. (US), Nipro (Japan), FUJIFILM Corporation (Japan), Hologic, Inc. (US), Shangrao WS Medtech Co., Ltd (China), Henke-Sass, Wolf (Germany), RUDOLF Medical GmbH + Co. KG (Germany), EndoMed Systems GmbH (Germany), Teleflex Incorporated (US), Integrated Endoscopy (US), NeoScope, Inc. (US), Ecleris (US), Nanchang WOEK Medical Technology Co., Ltd (China), Richard Wolf GmbH. (Germany), ATMOS MedizinTechnik GmbH & Co. KG (Germany), Kashmir Surgical Works. (India), Optomic (Spain), and HIPP ENDOSKOP SERVICE GMBH (Germany)

Research Coverage

This report examines the rigid endoscopes market by type, application, end user, and region. The report also examines key factors (including drivers, restraints, opportunities, and challenges) influencing market growth and provides an in-depth analysis of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as smaller entrants to gauge the market's pulse, which, in turn, will help them gain a larger market share. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market presence.

This report provides insights into the following pointers:

  • Analysis of key drivers (increasing investments, funds, and grants by government and other organizations, growing focus of hospitals to expand endoscopic units, increasing preference for minimally invasive surgeries, rising need for endoscopy to diagnose & treat target diseases), restraints (high overhead costs of endoscopy procedures, increased risk of getting infections during endoscopic procedures), opportunities (rapidly developing healthcare sector in emerging countries), challenges (increasing number of product recalls, lack of sterilization & reprocessing)
  • Market Penetration: Complete knowledge of the spectrum of products presented by the major companies in the rigid endoscopes market
  • Product Development/Innovation: Comprehensive understanding of the forthcoming trends, research and development initiatives, and product launches within the rigid endoscopes market
  • Market Development: Complete knowledge about profitable developing regions
  • Market Diversification: Exhaustive knowledge of new goods, expanding geographies, and current changes in the rigid endoscopes industry helps to diversify the market
  • Competitive Assessment: In-depth assessment of market share, growth strategies, and product offerings of leading players like Olympus Corporation (Japan), Karl Storz SE & CO. KG (Germany), Stryker (US), Nipro (Japan), EndoMed Systems GmbH (Germany), Richard Wolf GmbH. (Germany), Ambu A/S (Denmark), Smith+Nephew (UK), and others.
Show more
Product Code: MD 9564

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key objectives of secondary research
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key primary sources
      • 2.1.2.2 Key objectives of primary research
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Key data from primary sources
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
    • 2.2.2 TOP-DOWN APPROACH
    • 2.2.3 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS
    • 2.2.4 DEMAND-SIDE ANALYSIS (USING RIGID ENDOSCOPES)
  • 2.3 DATA TRIANGULATION
  • 2.4 MARKET RANKING ANALYSIS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.6.2 SCOPE-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 RIGID ENDOSCOPES MARKET OVERVIEW
  • 4.2 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY END USER AND COUNTRY
  • 4.3 RIGID ENDOSCOPES MARKET: GEOGRAPHIC MIX
  • 4.4 RIGID ENDOSCOPES MARKET: EMERGING VS. DEVELOPED ECONOMIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing preference for minimally invasive surgeries
      • 5.2.1.2 Increasing burden of chronic and lifestyle-related diseases
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High overhead costs
      • 5.2.2.2 Risk of viral infections during endoscopic procedures
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Rapidly developing healthcare sector in emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Product recalls
      • 5.2.4.2 Lack of sterilization and reprocessing
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 ADVANCED IMAGING TECHNOLOGIES
    • 5.3.2 MINIATURIZATION AND ULTRA-SLIM DESIGNS
  • 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE TREND A OF RIGID ENDOSCOPES, BY KEY PLAYER, 2022-2024
    • 5.5.2 AVERAGE PRICING TREND OF RIGID ENDOSCOPES, BY REGION, 2022-2024
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 SUPPLY CHAIN ANALYSIS
  • 5.8 ECOSYSTEM ANALYSIS
  • 5.9 INVESTMENT & FUNDING SCENARIO
  • 5.10 TECHNOLOGY ANALYSIS
    • 5.10.1 KEY TECHNOLOGIES
      • 5.10.1.1 Illumination technology
    • 5.10.2 COMPLEMENTARY TECHNOLOGIES
      • 5.10.2.1 Surgical visualization
    • 5.10.3 ADJACENT TECHNOLOGIES
      • 5.10.3.1 3D endoscopic visualization
  • 5.11 TRADE ANALYSIS
    • 5.11.1 IMPORT DATA FOR HS CODE 9018, 2019-2024
    • 5.11.2 EXPORT DATA FOR HS CODE 9018, 2019-2024
  • 5.12 REGULATORY ANALYSIS
    • 5.12.1 REGULATORY LANDSCAPE
      • 5.12.1.1 North America
        • 5.12.1.1.1 US
        • 5.12.1.1.2 Canada
      • 5.12.1.2 Europe
      • 5.12.1.3 Asia Pacific
        • 5.12.1.3.1 Japan
        • 5.12.1.3.2 China
        • 5.12.1.3.3 India
      • 5.12.1.4 Latin America
      • 5.12.1.5 Middle East & Africa
    • 5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.13 PATENT ANALYSIS
    • 5.13.1 PATENT PUBLICATION TREND
    • 5.13.2 JURISDICTION AND TOP APPLICANT ANALYSIS
    • 5.13.3 LIST OF PATENTS
  • 5.14 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.15 PORTER'S FIVE FORCES ANALYSIS
    • 5.15.1 THREAT OF NEW ENTRANTS
    • 5.15.2 THREAT OF SUBSTITUTES
    • 5.15.3 BARGAINING POWER OF BUYERS
    • 5.15.4 BARGAINING POWER OF SUPPLIERS
    • 5.15.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.16 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.16.2 BUYING CRITERIA
  • 5.17 ADJACENT MARKET ANALYSIS
    • 5.17.1 FLEXIBLE ENDOSCOPES MARKET
  • 5.18 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.19 IMPACT OF AI/GEN AI ON RIGID ENDOSCOPES MARKET
    • 5.19.1 INTRODUCTION
    • 5.19.2 AI USE CASES
    • 5.19.3 KEY COMPANIES IMPLEMENTING AI
    • 5.19.4 FUTURE OF GENERATIVE AI ON RIGID ENDOSCOPES MARKET
  • 5.20 IMPACT OF 2025 US TARIFFS ON RIGID ENDOSCOPES MARKET
    • 5.20.1 INTRODUCTION
    • 5.20.2 KEY TARIFF RATES
    • 5.20.3 PRICE IMPACT ANALYSIS
    • 5.20.4 IMPACT ON REGION
      • 5.20.4.1 North America
      • 5.20.4.2 Europe
      • 5.20.4.3 Asia Pacific
    • 5.20.5 IMPACT ON END-USE INDUSTRY

6 RIGID ENDOSCOPES MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 LAPAROSCOPES
    • 6.2.1 RISING GLOBAL PREVALENCE OF GYNECOLOGICAL AND CANCER CONDITIONS TO PROPEL MARKET GROWTH
  • 6.3 UROLOGY ENDOSCOPES
    • 6.3.1 RISING UROLOGICAL DISORDERS AND TECHNOLOGICAL ADVANCES TO DRIVE GROWTH IN UROLOGY ENDOSCOPES SEGMENT
  • 6.4 GYNECOLOGY ENDOSCOPES
    • 6.4.1 INCREASING PREVALENCE OF GYNECOLOGICAL CANCERS AMONG WOMEN TO AID MARKET GROWTH
  • 6.5 ARTHROSCOPES
    • 6.5.1 RISING GERIATRIC POPULATION AND GROWING INCIDENCE OF ORTHOPEDIC DISEASES TO BOOST MARKET GROWTH
  • 6.6 CYSTOSCOPES
    • 6.6.1 RISING BLADDER CANCER CASES AND MINIMALLY INVASIVE BENEFITS TO DRIVE CYSTOSCOPES MARKET GROWTH
  • 6.7 NEUROENDOSCOPES
    • 6.7.1 RISING NEUROLOGICAL DISORDERS AND INVESTMENTS IN ADVANCED CARE TO DRIVE MARKET GROWTH
  • 6.8 OTHER RIGID ENDOSCOPES

7 RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE

  • 7.1 INTRODUCTION
  • 7.2 SURGICAL USAGE
    • 7.2.1 RISING ADOPTION OF MINIMALLY INVASIVE SURGERIES TO DRIVE SEGMENTAL GROWTH
  • 7.3 DIAGNOSTIC USAGE
    • 7.3.1 GROWING DEMAND FOR OFFICE-BASED ENT, GYNECOLOGY, AND UROLOGY PROCEDURES TO ACCELERATE GROWTH

8 RIGID ENDOSCOPES MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 LAPAROSCOPY
    • 8.2.1 BROAD CLINICAL APPLICABILITY AND STRONG PROCEDURAL DEMAND ACROSS DIAGNOSTIC AND THERAPEUTIC INTERVENTIONS TO AID GROWTH
  • 8.3 UROLOGY ENDOSCOPY
    • 8.3.1 RISING PREVALENCE OF URINARY TRACT DISEASES AND CANCERS TO FUEL MARKET
  • 8.4 ARTHROSCOPY
    • 8.4.1 INCREASING PREVALENCE OF ARTHRITIS AMONG AGING POPULATION TO SPUR GROWTH
  • 8.5 NEUROENDOSCOPY
    • 8.5.1 FAVORABLE GOVERNMENT AND PRIVATE SECTOR POLICIES TO SUPPORT ADOPTION OF NEUROENDOSCOPES
  • 8.6 OTHER APPLICATIONS

9 RIGID ENDOSCOPES MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS
    • 9.2.1 ROBUST SURGICAL INFRASTRUCTURE AND LARGE PATIENT BASE TO FOSTER GROWTH
  • 9.3 AMBULATORY SURGERY CENTERS
    • 9.3.1 GROWING PREFERENCE FOR OUTPATIENT SURGERIES AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET
  • 9.4 CLINICS
    • 9.4.1 RISING ADOPTION OF OUTPATIENT DIAGNOSTICS AND DECENTRALIZED HEALTHCARE TO AID GROWTH
  • 9.5 OTHER END USERS

10 RIGID ENDOSCOPES MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 10.2.2 US
      • 10.2.2.1 US to dominate North American rigid endoscopes market during forecast period
    • 10.2.3 CANADA
      • 10.2.3.1 Rising chronic disease prevalence among aging population to drive market
  • 10.3 EUROPE
    • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 10.3.2 GERMANY
      • 10.3.2.1 Germany to dominate European rigid endoscopes market
    • 10.3.3 UK
      • 10.3.3.1 Increased aging population, high cancer prevalence, and strong healthcare infrastructure to drive market growth
    • 10.3.4 FRANCE
      • 10.3.4.1 Increase in health expenditure and high prevalence of cancer to stimulate market growth
    • 10.3.5 ITALY
      • 10.3.5.1 Increasing prevalence of chronic diseases to boost adoption
    • 10.3.6 SPAIN
      • 10.3.6.1 Rising aging population to drive market growth
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 10.4.2 CHINA
      • 10.4.2.1 China to dominate Asia Pacific rigid endoscopes market during forecast period
    • 10.4.3 JAPAN
      • 10.4.3.1 Increasing chronic disease prevalence and rising geriatric population to drive growth
    • 10.4.4 INDIA
      • 10.4.4.1 Rising osteoarthritis and cancer prevalence to drive market growth
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Advancing healthcare infrastructure to support rigid endoscopes adoption in Australia
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Super-aged society and high disease prevalence to drive growth in South Korean market
    • 10.4.7 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 10.5.2 BRAZIL
      • 10.5.2.1 Brazil to account for largest share of Latin American market
    • 10.5.3 MEXICO
      • 10.5.3.1 Increasing minimally invasive procedures to support rigid endoscopes adoption
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 High healthcare investments and hospital expansions to drive market growth
    • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN RIGID ENDOSCOPES MARKET
  • 11.3 REVENUE ANALYSIS, 2020-2024
  • 11.4 MARKET SHARE ANALYSIS, 2024
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 11.5.5.1 Company footprint
      • 11.5.5.2 Region footprint
      • 11.5.5.3 Type footprint
      • 11.5.5.4 Application footprint
      • 11.5.5.5 End-user footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 11.6.5.1 Detailed list of key startups/SMEs
      • 11.6.5.2 Competitive benchmarking of key startups/SMEs
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
    • 11.7.1 FINANCIAL METRICS
    • 11.7.2 COMPANY VALUATION
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES
    • 11.9.2 DEALS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 OLYMPUS CORPORATION
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Deals
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Right to win
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses & competitive threats
    • 12.1.2 KARL STORZ SE & CO. KG
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Product launches
        • 12.1.2.3.2 Deals
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Right to win
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses & competitive threats
    • 12.1.3 STRYKER
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products offered
      • 12.1.3.3 MnM view
        • 12.1.3.3.1 Right to win
        • 12.1.3.3.2 Strategic choices
        • 12.1.3.3.3 Weaknesses & competitive threats
    • 12.1.4 SMITH+NEPHEW
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 MnM view
        • 12.1.4.3.1 Right to win
        • 12.1.4.3.2 Strategic choices
        • 12.1.4.3.3 Weaknesses & competitive threats
    • 12.1.5 B. BRAUN SE
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
      • 12.1.5.3 MnM view
        • 12.1.5.3.1 Right to win
        • 12.1.5.3.2 Strategic choices
        • 12.1.5.3.3 Weaknesses & competitive threat
    • 12.1.6 MEDTRONIC
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
      • 12.1.6.3 Recent developments
        • 12.1.6.3.1 Deals
    • 12.1.7 NIPRO
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered
    • 12.1.8 RICHARD WOLF GMBH
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Deals
    • 12.1.9 CONMED CORPORATION
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products offered
    • 12.1.10 ARTHREX, INC.
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products offered
  • 12.2 OTHER PLAYERS
    • 12.2.1 FUJIFILM CORPORATION
    • 12.2.2 HOLOGIC, INC.
    • 12.2.3 SHANGRAO WS MEDTECH CO., LTD.
    • 12.2.4 ATMOS MEDIZINTECHNIK GMBH & CO. KG
    • 12.2.5 HENKE-SASS WOLF
    • 12.2.6 RUDOLF MEDICAL GMBH + CO. KG
    • 12.2.7 ENDOMED SYSTEMS GMBH
    • 12.2.8 TELEFLEX INCORPORATED
    • 12.2.9 INTEGRATED ENDOSCOPY
    • 12.2.10 NEOSCOPE INC.
    • 12.2.11 ECLERIS
    • 12.2.12 NANCHANG WOEK MEDICAL TECHNOLOGY CO., LTD
    • 12.2.13 KASHMIR SURGICAL WORKS
    • 12.2.14 OPTOMIC
    • 12.2.15 HIPP ENDOSKOP SERVICE GMBH

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
Show more
Product Code: MD 9564

List of Tables

  • TABLE 1 RIGID ENDOSCOPES MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATES, 2019-2024
  • TABLE 3 RIGID ENDOSCOPES MARKET: STUDY ASSUMPTIONS
  • TABLE 4 RIGID ENDOSCOPES MARKET: RISK ASSESSMENT
  • TABLE 5 PRODUCT RECALLS BY KEY PLAYERS, 2024-2025
  • TABLE 6 AVERAGE SELLING PRICE TREND OF RIGID ENDOSCOPES, BY KEY PLAYER, 2022-2024 (USD)
  • TABLE 7 AVERAGE SELLING PRICE TREND OF RIGID ENDOSCOPES, BY REGION, 2022-2024 (USD)
  • TABLE 8 IMPORT DATA FOR RIGID ENDOSCOPES UNDER HS CODE 9018, BY COUNTRY, 2019-2024 (USD THOUSAND)
  • TABLE 9 EXPORT DATA FOR RIGID ENDOSCOPES UNDER HS CODE 9018, BY COUNTRY, 2019-2024 (USD THOUSAND)
  • TABLE 10 CLASSIFICATION OF MEDICAL DEVICES BY US FDA
  • TABLE 11 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 12 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 13 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES IN JAPAN
  • TABLE 14 NMPA MEDICAL DEVICES CLASSIFICATION
  • TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 RIGID ENDOSCOPES MARKET: LIST OF PATENTS, 2022-2025
  • TABLE 21 RIGID ENDOSCOPES MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
  • TABLE 22 RIGID ENDOSCOPES MARKET: PORTER'S FIVE FORCES
  • TABLE 23 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF TOP THREE APPLICATIONS
  • TABLE 24 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • TABLE 25 RIGID ENDOSCOPES MARKET: UNMET NEEDS/END-USER EXPECTATIONS
  • TABLE 26 KEY COMPANIES IMPLEMENTING AI IN RIGID ENDOSCOPES MARKET
  • TABLE 27 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 28 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR RIGID ENDOSCOPES
  • TABLE 29 RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 30 LAPAROSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 31 UROLOGY ENDOSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 32 GYNECOLOGY ENDOSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 33 ARTHROSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 34 CYSTOSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 35 NEUROENDOSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 OTHER RIGID ENDOSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 38 RIGID ENDOSCOPES MARKET FOR SURGICAL USAGE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 39 RIGID ENDOSCOPES MARKET FOR DIAGNOSTIC USAGE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 40 RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 41 RIGID ENDOSCOPES MARKET FOR LAPAROSCOPY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 RIGID ENDOSCOPES MARKET FOR UROLOGY ENDOSCOPY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 RIGID ENDOSCOPES MARKET FOR ARTHROSCOPY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 44 RIGID ENDOSCOPES MARKET FOR NEUROENDOSCOPY, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 45 RIGID ENDOSCOPES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 46 RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 47 RIGID ENDOSCOPES MARKET FOR HOSPITALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 48 RIGID ENDOSCOPES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 49 RIGID ENDOSCOPES MARKET FOR CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 RIGID ENDOSCOPES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 51 RIGID ENDOSCOPES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 52 RIGID ENDOSCOPES MARKET, BY REGION, 2023-2030 (THOUSAND UNITS)
  • TABLE 53 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 54 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 55 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (THOUSAND UNITS)
  • TABLE 56 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 57 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 58 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 59 US: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 60 US: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 61 US: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 62 US: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 63 CANADA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 64 CANADA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 65 CANADA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 66 CANADA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 67 EUROPE: RIGID ENDOSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 68 EUROPE: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 69 EUROPE: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (THOUSAND UNITS)
  • TABLE 70 EUROPE: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 71 EUROPE: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 72 EUROPE: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 73 GERMANY: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 74 GERMANY: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 75 GERMANY: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 76 GERMANY: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 77 UK: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 78 UK: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 79 UK: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 80 UK: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 81 FRANCE: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 82 FRANCE: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 83 FRANCE: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 84 FRANCE: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 85 ITALY: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 86 ITALY: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 87 ITALY: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 88 ITALY: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 89 SPAIN: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 90 SPAIN: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 91 SPAIN: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 92 SPAIN: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 93 REST OF EUROPE: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 94 REST OF EUROPE: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 95 REST OF EUROPE: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 96 REST OF EUROPE: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 98 ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 99 ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (THOUSAND UNITS)
  • TABLE 100 ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 101 ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 102 ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 103 CHINA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 104 CHINA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 105 CHINA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 106 CHINA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 107 JAPAN: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 108 JAPAN: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 109 JAPAN: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 110 JAPAN: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 111 INDIA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 112 INDIA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 113 INDIA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 114 INDIA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 115 AUSTRALIA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 116 AUSTRALIA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 117 AUSTRALIA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 118 AUSTRALIA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 119 SOUTH KOREA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 120 SOUTH KOREA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 121 SOUTH KOREA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 122 SOUTH KOREA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 123 REST OF ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 124 REST OF ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 125 REST OF ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 126 REST OF ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 127 LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 128 LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 129 LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (THOUSAND UNITS)
  • TABLE 130 LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 131 LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 132 LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 133 BRAZIL: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 134 BRAZIL: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 135 BRAZIL: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 136 BRAZIL: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 137 MEXICO: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 138 MEXICO: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 139 MEXICO: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 140 MEXICO: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 141 REST OF LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 142 REST OF LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 143 REST OF LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 144 REST OF LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 145 MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 146 MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 147 MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (THOUSAND UNITS)
  • TABLE 148 MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 149 MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 150 MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 151 GCC COUNTRIES: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 152 GCC COUNTRIES: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 153 GCC COUNTRIES: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 154 GCC COUNTRIES: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 155 REST OF MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 156 REST OF MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023-2030 (USD MILLION)
  • TABLE 157 REST OF MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 158 REST OF MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 159 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN RIGID ENDOSCOPES MARKET
  • TABLE 160 RIGID ENDOSCOPES MARKET: DEGREE OF COMPETITION
  • TABLE 161 RIGID ENDOSCOPES MARKET: REGION FOOTPRINT
  • TABLE 162 RIGID ENDOSCOPES MARKET: TYPE FOOTPRINT
  • TABLE 163 RIGID ENDOSCOPES MARKET: APPLICATION FOOTPRINT
  • TABLE 164 RIGID ENDOSCOPES MARKET: END-USER FOOTPRINT
  • TABLE 165 RIGID ENDOSCOPES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 166 RIGID ENDOSCOPES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY TYPE AND REGION
  • TABLE 167 RIGID ENDOSCOPES MARKET: PRODUCT LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 168 RIGID ENDOSCOPES MARKET: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 169 OLYMPUS CORPORATION: COMPANY OVERVIEW
  • TABLE 170 OLYMPUS CORPORATION: PRODUCTS OFFERED
  • TABLE 171 OLYMPUS CORPORATION: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 172 KARL STORZ SE & CO. KG: COMPANY OVERVIEW
  • TABLE 173 KARL STORZ SE & CO. KG: PRODUCTS OFFERED
  • TABLE 174 KARL STORZ SE & CO. KG: PRODUCT LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 175 KARL STORZ SE & CO. KG: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 176 STRYKER: COMPANY OVERVIEW
  • TABLE 177 STRYKER: PRODUCTS OFFERED
  • TABLE 178 SMITH+NEPHEW: COMPANY OVERVIEW
  • TABLE 179 SMITH+NEPHEW: PRODUCTS OFFERED
  • TABLE 180 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 181 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 182 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 183 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 184 MEDTRONIC: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 185 NIPRO: COMPANY OVERVIEW
  • TABLE 186 NIPRO: PRODUCTS OFFERED
  • TABLE 187 RICHARD WOLF GMBH: COMPANY OVERVIEW
  • TABLE 188 RICHARD WOLF GMBH: PRODUCTS OFFERED
  • TABLE 189 RICHARD WOLF GMBH: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 190 CONMED CORPORATION: COMPANY OVERVIEW
  • TABLE 191 CONMED CORPORATION: PRODUCTS OFFERED
  • TABLE 192 ARTHREX, INC.: COMPANY OVERVIEW
  • TABLE 193 ARTHREX, INC.: PRODUCTS OFFERED
  • TABLE 194 FUJIFILM CORPORATION: COMPANY OVERVIEW
  • TABLE 195 HOLOGIC, INC.: COMPANY OVERVIEW
  • TABLE 196 SHANGRAO WS MEDTECH CO., LTD.: COMPANY OVERVIEW
  • TABLE 197 ATMOS MEDIZINTECHNIK GMBH & CO. KG: COMPANY OVERVIEW
  • TABLE 198 HENKE-SASS WOLF: COMPANY OVERVIEW
  • TABLE 199 RUDOLF MEDICAL GMBH + CO. KG: COMPANY OVERVIEW
  • TABLE 200 ENDOMED SYSTEMS GMBH: COMPANY OVERVIEW
  • TABLE 201 TELEFLEX INCORPORATED: COMPANY OVERVIEW
  • TABLE 202 INTEGRATED ENDOSCOPY: COMPANY OVERVIEW
  • TABLE 203 NEOSCOPE INC.: COMPANY OVERVIEW
  • TABLE 204 ECLERIS: COMPANY OVERVIEW
  • TABLE 205 NANCHANG WOEK MEDICAL TECHNOLOGY CO., LTD: COMPANY OVERVIEW
  • TABLE 206 KASHMIR SURGICAL WORKS: COMPANY OVERVIEW
  • TABLE 207 OPTOMIC: COMPANY OVERVIEW
  • TABLE 208 HIPP ENDOSKOP SERVICE GMBH: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 RIGID ENDOSCOPES MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 RIGID ENDOSCOPES MARKET: YEARS CONSIDERED
  • FIGURE 3 RIGID ENDOSCOPES MARKET: RESEARCH DESIGN
  • FIGURE 4 RIGID ENDOSCOPES MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 RIGID ENDOSCOPES MARKET: KEY PRIMARY SOURCES
  • FIGURE 6 RIGID ENDOSCOPES MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 7 RIGID ENDOSCOPES MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 8 PRIMARY BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 9 RIGID ENDOSCOPES MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 10 RIGID ENDOSCOPES MARKET: TOP-DOWN APPROACH
  • FIGURE 11 IMPACT ANALYSIS OF MARKET DYNAMICS, 2025-2030
  • FIGURE 12 RIGID ENDOSCOPES MARKET: CAGR PROJECTIONS
  • FIGURE 13 RIGID ENDOSCOPES MARKET: DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 RIGID ENDOSCOPES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 RIGID ENDOSCOPES MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 RIGID ENDOSCOPES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 REGIONAL SNAPSHOT OF RIGID ENDOSCOPES MARKET
  • FIGURE 19 RISING REQUIREMENT FOR ENDOSCOPY TO DIAGNOSE AND TREAT TARGET DISEASES TO DRIVE MARKET GROWTH
  • FIGURE 20 US AND HOSPITALS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN RIGID ENDOSCOPES MARKET IN 2024
  • FIGURE 21 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 22 MIDDLE EAST & AFRICA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 24 RIGID ENDOSCOPES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 25 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS IN RIGID ENDOSCOPES MARKET
  • FIGURE 26 RIGID ENDOSCOPES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 27 RIGID ENDOSCOPES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 28 RIGID ENDOSCOPES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 29 RIGID ENDOSCOPES MARKET: FUNDING SCENARIO AND NUMBER OF DEALS, 2019-2023 (USD MILLION)
  • FIGURE 30 RIGID ENDOSCOPES MARKET: PATENT ANALYSIS, JANUARY 2015-SEPTEMBER 2025
  • FIGURE 31 TOP APPLICANTS FOR RIGID ENDOSCOPES, JANUARY 2015-SEPTEMBER 2025
  • FIGURE 32 RIGID ENDOSCOPES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 33 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF TOP THREE APPLICATIONS
  • FIGURE 34 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • FIGURE 35 FLEXIBLE ENDOSCOPES MARKET OVERVIEW
  • FIGURE 36 AI USE CASES IN RIGID ENDOSCOPES MARKET
  • FIGURE 37 RIGID ENDOSCOPES MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 38 NORTH AMERICA: RIGID ENDOSCOPES MARKET SNAPSHOT
  • FIGURE 39 ASIA PACIFIC: RIGID ENDOSCOPES MARKET SNAPSHOT
  • FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN RIGID ENDOSCOPES MARKET (2020-2024)
  • FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN RIGID ENDOSCOPES MARKET (2024)
  • FIGURE 42 RIGID ENDOSCOPES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 43 RIGID ENDOSCOPES MARKET: COMPANY FOOTPRINT
  • FIGURE 44 RIGID ENDOSCOPES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 45 EV/EBITDA OF KEY VENDORS
  • FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 47 RIGID ENDOSCOPES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 48 OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 49 STRYKER: COMPANY SNAPSHOT
  • FIGURE 50 SMITH+NEPHEW: COMPANY SNAPSHOT
  • FIGURE 51 B. BRAUN SE: COMPANY SNAPSHOT
  • FIGURE 52 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 53 NIPRO: COMPANY SNAPSHOT
  • FIGURE 54 CONMED CORPORATION: COMPANY SNAPSHOT
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!